Literature DB >> 34388049

Chromophobe Renal Cell Carcinoma with Radiologic-Pathologic Correlation.

Jamie Marko1, Ryan Craig1, Andrew Nguyen1, Aaron M Udager1, Darcy J Wolfman1.   

Abstract

Renal cell carcinoma (RCC) is a heterogeneous group of neoplasms derived from the renal tubular epithelial cells. Chromophobe RCC (chRCC) is the third most common subtype of RCC, accounting for 5% of cases. chRCC may be detected as an incidental finding or less commonly may manifest with clinical symptoms. The mainstay of therapy for chRCC is surgical resection. chRCC has a better prognosis compared with the more common clear cell RCC. At gross pathologic analysis, chRCC is a solid well-defined mass with lobulated borders. Histologic findings vary by subtype but include large pale polygonal cells with abundant transparent cytoplasm, crinkled "raisinoid" nuclei with perinuclear halos, and prominent cell membranes. Pathologic analysis reveals only moderate vascularity. The most common imaging pattern is a predominantly solid renal mass with circumscribed margins and enhancement less than that of the renal cortex. The authors discuss chRCC with emphasis on correlative pathologic findings and illustrate the multimodality imaging appearances of chRCC by using cases from the Radiologic Pathology Archives of the American Institute for Radiologic Pathology. ©RSNA, 2021.

Entities:  

Mesh:

Year:  2021        PMID: 34388049      PMCID: PMC8415046          DOI: 10.1148/rg.2021200206

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   6.312


  47 in total

1.  Diffusion-weighted imaging versus contrast-enhanced MR imaging for the differentiation of renal oncocytomas and chromophobe renal cell carcinomas.

Authors:  Yan Zhong; Haiyi Wang; Yanguang Shen; Aitao Guo; Jia Wang; Suhai Kang; Lu Ma; Jingjing Pan; Huiyi Ye
Journal:  Eur Radiol       Date:  2017-06-19       Impact factor: 5.315

2.  Guideline for management of the clinical T1 renal mass.

Authors:  Steven C Campbell; Andrew C Novick; Arie Belldegrun; Michael L Blute; George K Chow; Ithaar H Derweesh; Martha M Faraday; Jihad H Kaouk; Raymond J Leveillee; Surena F Matin; Paul Russo; Robert G Uzzo
Journal:  J Urol       Date:  2009-08-14       Impact factor: 7.450

Review 3.  Differentiation of Solid Renal Tumors with Multiparametric MR Imaging.

Authors:  Camila Lopes Vendrami; Carolina Parada Villavicencio; Todd J DeJulio; Argha Chatterjee; David D Casalino; Jeanne M Horowitz; Daniel T Oberlin; Guang-Yu Yang; Paul Nikolaidis; Frank H Miller
Journal:  Radiographics       Date:  2017 Nov-Dec       Impact factor: 5.333

4.  Can we better select patients with metastatic renal cell carcinoma for cytoreductive nephrectomy?

Authors:  Stephen H Culp; Nizar M Tannir; E Jason Abel; Vitaly Margulis; Pheroze Tamboli; Surena F Matin; Christopher G Wood
Journal:  Cancer       Date:  2010-07-15       Impact factor: 6.860

Review 5.  Genomic classifications of renal cell carcinoma: a critical step towards the future application of personalized kidney cancer care with pan-omics precision.

Authors:  James J Hsieh; Valerie Le; Dengfeng Cao; Emily H Cheng; Chad J Creighton
Journal:  J Pathol       Date:  2018-02-14       Impact factor: 7.996

Review 6.  The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications.

Authors:  W Marston Linehan; Christopher J Ricketts
Journal:  Nat Rev Urol       Date:  2019-07-05       Impact factor: 14.432

7.  Renal Cell Carcinomas: Sonographic Appearance Depending on Size and Histologic Type.

Authors:  Kunal Sidhar; John P McGahan; Heather M Early; Michael Corwin; Ghaneh Fananapazir; Eugenio O Gerscovich
Journal:  J Ultrasound Med       Date:  2016-01-06       Impact factor: 2.153

8.  Laparoscopic radical versus partial nephrectomy for tumors >4 cm: intermediate-term oncologic and functional outcomes.

Authors:  Matthew N Simmons; Christopher J Weight; Inderbir S Gill
Journal:  Urology       Date:  2009-05       Impact factor: 2.649

9.  Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes--correlation with pathologic findings.

Authors:  Maryellen R M Sun; Long Ngo; Elizabeth M Genega; Michael B Atkins; Myra E Finn; Neil M Rofsky; Ivan Pedrosa
Journal:  Radiology       Date:  2009-03       Impact factor: 11.105

10.  Systemic therapy for chromophobe renal cell carcinoma: A systematic review.

Authors:  Dimitrios Papanikolaou; Pinelopi Ioannidou; Periklis Koukourikis; Kyriakos Moysidis; Soultana Meditskou; Dimitrios Koutsoumparis; Konstantinos Hatzimouratidis; Eudoxia Hatzivassiliou
Journal:  Urol Oncol       Date:  2020-01-15       Impact factor: 3.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.